Mar 22 2012
In this post in USAID's "IMPACTblog," guest blogger Joanna Breitstein, director of communications for the TB Alliance, describes an event organized by the Critical Paths to TB Drug Regimens that took place on Monday, "heralding the launch of a new clinical trial that tests tuberculosis drugs in combination." During the event, "Robert Clay, deputy assistant administrator in USAID's Global Health Bureau, said that he wants researchers and those who oversee programs in countries to work more closely together," she writes. A link to video of Clay's comments is included in the blog (3/20).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|